Cancer of the hepatic flexure of the colon is a type of colorectal cancer that occurs at the bend where the ascending colon meets the transverse colon. The exact causes are not entirely understood, but risk factors include a diet high in red and processed meats, low fiber intake, smoking, heavy alcohol consumption, and a family history of colorectal cancer. Symptoms may include abdominal pain, changes in bowel habits, blood in the stool, unexplained weight loss, and fatigue. Diagnosis typically involves a combination of physical exams, blood tests, imaging tests like CT scans, and a colonoscopy with biopsy to confirm the presence of cancerous cells. Early detection is critical for successful treatment outcomes.
Treatment for cancer of the hepatic flexure of the colon often involves a multimodal approach. Surgery is usually the primary treatment and involves removing the cancerous section of the colon along with nearby lymph nodes. This procedure is called a colectomy. Depending on the stage and spread of the cancer, chemotherapy may be administered before or after surgery to shrink tumors or eliminate remaining cancer cells. Radiation therapy might be used in certain cases to target and destroy cancer cells. Targeted therapies and immunotherapy are also emerging treatment options that use the body’s immune system to fight cancer or target specific cancer cell mechanisms. Post-treatment, regular follow-ups and lifestyle changes, such as a healthy diet and regular exercise, are recommended to reduce the risk of recurrence.
Mrs. Joyce Njeri Kinyua from Kenya successfully received treatment for the Cancer of Hepatic Flexure of Colon at Yashoda Hospitals, Hyderabad, under the supervision of Dr. Sachin Marda, Clinical Director, Senior Oncologist and Robotic Surgeon.